Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class ii alleles in chronic fatigue syndrome: Are they associated with age at onset and specific symptoms

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 589-599

  Ortega Hernandez, Oscar Danilo ^a   Cuccia, Mariaclara ^b   Bozzini, Sara ^b   Bassi, Nicola ^c   Moscavitch, Samuel ^a   Diaz Gallo, Lina Marcela ^d   Blank, Miri ^a   Agmon Levin, Nancy ^a   Shoenfeld, Yehuda ^a,e  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d Unidad de Biología Celular y Molecular   (Colombia)

^e SHEBA MEDICAL CENTER   (Israel)

Author keywords

Autoantibodies; Autoimmunity; Chronic fatigue syndrome; HLA DR; Psychiatric disorders; Serotonin transporter and receptor polymorphisms

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; HLA ANTIGEN CLASS 2; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER;

ADULT; ARTHRALGIA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; CHRONIC FATIGUE SYNDROME; CLINICAL EXAMINATION; CONFERENCE PAPER; CORRELATION ANALYSIS; DEPRESSION; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYALGIA; ONSET AGE; PREVALENCE; PYREXIA IDIOPATHICA; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 69949177920     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04802.x     Document Type: Conference Paper

References (39)

1. Holmes G.P., J.E. Kaplan, N.M. Gantz, et al. 1988. Chronic fatigue syndrome: a working case definition. Ann. Intern. Med. 108: 387-389.
2. Buchwald D., P. Umali, J. Umali, et al. 1995. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system. Ann. Intern. Med. 123: 81-88.
3. Appel, S., J. Chapman & Y. Shoenfeld. 2007. Infection and vaccination in chronic fatigue syndrome: myth or reality? Autoimmunity 40: 48-53.
4. Carlo-Stella N., C. Badulli, A. De Silvestri, et al. 2006. A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles. Clin. Exp. Rheumatol. 24: 179-182.
5. Golden H.E. 1995. Clinical laboratory test findings in patients with chronic fatigue syndrome. Arch. Intern. Med. 155: 1332.
6. Appel S. J. Chapman & Y. Shoenfeld. 2007. Infection and vaccination in chronic fatigue syndrome: myth or reality? Autoimmunity 40: 48-53.
7. Konstantinov K., A. von Mikecz, D. Buchwald, et al. 1996. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J. Clin. Invest. 98: 1888-1896.
8. Bassi, N., D. Amital, H. Amital, et al. 2008. Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis. Isr. Med. Assoc. J. 10: 79-82.
9. Smith, J., E.L. Fritz, J.R. Kerr, et al. 2005. Association of chronic fatigue syndrome with human leucocyte antigen class II alleles. J. Clin. Pathol. 58: 860-863.
10. Narita, M., N. Nishigami, N. Narita, et al. 2003. Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem. Biophys. Res. Commun. 311: 264-266.
11. Smith, A.K., I. Dimulescu, V.R. Falkenberg, et al. 2008. Genetic evaluation of the serotonergic system in chronic fatigue syndrome. Psychoneuroendocrinology 33: 188-197.
12. Gotlib, I.H., J. Joormann, K.L. Minor & J. Hallmayer. 2008. HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression. Biol. Psychiatry 63: 847-851.
13. Fukuda K., S.E. Straus, I. Hickie, et al. 1994. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 121: 953-959.
14. Reeves W.C., D. Wagner, R. Nisenbaum, et al. 2005. Chronic fatigue syndrome-a clinically empirical approach to its definition and study. BMC Med. 15: 3-19.
15. Watanabe, N., R. Stewart, R. Jenkins, et al. 2008. The epidemiology of chronic fatigue, physical illness, and symptoms of common mental disorders: a cross-sectional survey from the second British National Survey of Psychiatric Morbidity. J. Psychosom. Res. 64: 357-362.
16. Heils, A., A. Teufel, S. Petri, et al. 1996. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66: 2621-2624.
17. Chee, I.S., S.W. Lee, J.L. Kim, et al. 2001. 5-HT2A receptor gene promoter polymorphism-1438A/G and bipolar disorder. Psychiatr. Genet. 11: 111-114.
18. Coenen, M.J.H. & P.K. Gregersen. 2008. Rheumatoid arthritis: a view of the current genetic landscape. Genes Immun. Epub 2008 Nov 6: doi: 10.1038/gene.2008.77.
19. Shoenfeld, Y., B. Gilburd, M. Abu-Shakra, et al. 2008. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases-2008. Isr. Med. As-soc. J. 10: 3-7.
20. Dupont, B. 1989. Nomenclature for factors of the HLA system, 1987. Decisions of the Nomenclature Committee on Leukocyte Antigens, which met in New York on November 21-23, 1987. Hum. Immunol. 26: 3-14.
21. Marsh, S.G., WHO Nomenclature Committee for Factors of the HLA System. 2008. Nomenclature for factors of the HLA system, update January 2008. Tissue Antigens 71: 580-581.
22. Zandman-Goddard G., J. Chapman & Y. Shoenfeld. 2007. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin. Arthritis Rheum. 36: 297-315.
23. Grunebaum, E., M. Blank, S. Cohen, et al. 2002. The role of anti-endothelial cell antibodies in Kawasaki disease-in vitro and in vivo studies. Clin. Exp. Immunol. 130: 233-240.
24. Marai, I., B. Gilburd, M. Blank & Y. Shoenfeld. 2003. Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome. Hum. Antibodies 12: 57-62.
25. Excoffier, L., G. Laval & D. Balding. 2003. Gametic phase estimation over large genomic regions using an adaptive window approach. Hum. Genomics 1: 7-19.
26. Excoffier, L.G., Laval & S. Schneider. 2005. Arlequin version 3.0: An integrated software package for population genetics data analysis. Evolut. Bioinform. Online 1: 47-50.
27. Nishikai, M., K. Akiya, T. Tojo, et al. 1996. Seroneg-ative' Sjögren's syndrome manifested as a subset of chronic fatigue syndrome. Br. J. Rheumatol. 35: 471-474.
28. Shoenfeld, Y., G. Zandman-Goddard, L. Sto-janovich, et al. 2008. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases-2008. Isr. Med. Assoc. J. 10: 8-12. (Pubitemid 351649455)
29. Shoenfeld, Y., M. Blank, M. Abu-Shakra, et al. 2008. The mosaic of autoimmunity: prediction, autoanti-bodies, and theraphy in autoimmune diseases-2008. Isr. Med. Assoc. J. 10: 13-19.
30. Katon, W.J., D.S. Buchwald, G.E. Simon, et al. 1991. Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritis. J. G e n . I n t e r n . M e d . 6: 277-285.
31. Strous, R.D. & Y. Shoenfeld. 2006. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J. A u-toimmun. 27: 71-80.
32. Werle, E., H.P. Fischer, A. Müller, et al. 2001. Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome. J. Rheumatol. 28: 595-600.
33. Kang, R.H., M.J. Choi, J.W. Paik, et al. 2007. Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression. Int. J. Psychiatry Med. 37: 315-329.
34. Benedetti, F., C. Colombo, A. Serretti, et al. 2003. Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene. Biol. Psychiatry 54: 687-692.
35. Benedetti, F., B. Barbini, A. Bernasconi, et al. 2008. Serotonin 5-HT(2A) receptor gene variants influence antidepressant response to repeated total sleep deprivation in bipolar depression. Prog. Neuropsychopharma-col. Biol. Psychiatry 32: 1863-1866.
36. Tiersky, L.A., R.J. Matheis, J. Deluca, et al. 2003. Functional status, neuropsychological functioning, and mood in chronic fatigue syndrome (CFS): relationship to psychiatric disorder. J. N e r v. M e n t . D i s . 191: 324-331.
37. Moss-Morris, R. & K.J. Petrie. 2001. Discriminating between chronic fatigue syndrome and depression: a cognitive analysis. Psychol. Med. 31: 469-479.
38. Underhill, J.A., M. Mahalingam, M. Peakman & S. Wessely. 2001. Lack of association between HLA genotype and chronic fatigue syndrome. Eur. J. Im-munogenet. 28: 425-428.
39. Keller, R.H., J.L. Lane, N. Klimas, et al. 1994. Association between HLA class II antigens and the chronic fatigue immune dysfunction syndrome. Clin. Infect. Dis. 1: S154-156.